| # | Drug | Count |
|---|---|---|
| 0 | EVOLOCUMAB | 172 |
| 1 | ESTRADIOL | 127 |
| 2 | ERENUMAB-AOOE | 89 |
| 3 | ORAL SEMAGLUTIDE | 71 |
| 4 | ALBUTEROL SULFATE | 59 |
| 5 | DUPILUMAB | 57 |
| 6 | CYCLOSPORINE | 47 |
| 7 | ESTRADIOL GEL 0.1% | 45 |
| 8 | ESTRADIOL TRANSDERMAL | 45 |
| 9 | ESTRADIOL, | 45 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BROMFENAC OPHTHALMIC SOLUTION 0.09% | 2 | 0.0870 |
| 1 | TESTOSTERONE GEL, 1% | 3 | 0.0118 |
| 2 | FLUOROMETHOLONE ACETATE | 2 | 0.0075 |
| 3 | ALBUTEROL SULFATE AND BUDESONIDE | 9 | 0.0056 |
| 4 | ESTRADIOL AND LEVONORGESTREL | 9 | 0.0044 |
| 5 | CICLESONIDE | 27 | 0.0020 |
| 6 | ACLIDINIUM BROMIDE | 11 | 0.0017 |
| 7 | ERENUMAB-AOOE | 89 | 0.0016 |
| 8 | ARIPIPRAZOLE LAUROXIL | 7 | 0.0015 |
| 9 | INSULIN ASPART INJECTION | 4 | 0.0015 |
| # | Drug class | Count |
|---|---|---|
| 0 | PCSK9 Inhibitor [EPC] | 173 |
| 1 | Estrogen [EPC] | 139 |
| 2 | GLP-1 Receptor Agonist [EPC] | 90 |
| 3 | Corticosteroid [EPC] | 61 |
| 4 | Insulin Analog [EPC] | 57 |
| 5 | Interleukin-4 Receptor alpha Antagonist [EPC] | 57 |
| 6 | Calcineurin Inhibitor Immunosuppressant [EPC] | 48 |
| 7 | Nonsteroidal Anti-inflammatory Drug [EPC] | 38 |
| 8 | Prostaglandin Analog [EPC] | 30 |
| 9 | Tumor Necrosis Factor Blocker [EPC] | 29 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | PCSK9 Inhibitor [EPC] | 173 | 0.0067 |
| 1 | Interleukin-5 Antagonist [EPC] | 4 | 0.0058 |
| 2 | Polyene Antimicrobial [EPC] | 1 | 0.0024 |
| 3 | Serotonin-4 Receptor Agonist [EPC] | 1 | 0.0015 |
| 4 | Thymic Stromal Lymphopoietin Blocker [EPC] | 6 | 0.0009 |
| 5 | Estrogen [EPC] | 139 | 0.0007 |
| 6 | Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC] | 13 | 0.0006 |
| 7 | Progesterone [EPC] | 14 | 0.0006 |
| 8 | Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC] | 1 | 0.0006 |
| 9 | Endoglycosidase [EPC] | 1 | 0.0005 |